These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 34242398)

  • 21. A New Class of Topical Acne Treatment Addressing the Hormonal Pathogenesis of Acne.
    Barbieri JS
    JAMA Dermatol; 2020 Jun; 156(6):619-620. PubMed ID: 32320045
    [No Abstract]   [Full Text] [Related]  

  • 22. Game Changer in Acne Treatment.
    Kircik LH
    J Drugs Dermatol; 2020 Mar; 19(3):28. PubMed ID: 32550698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Androgen Receptor Inhibitors in the Treatment of Acne Vulgaris: Efficacy and Safety Profiles of Clascoterone 1% Cream.
    Sanchez C; Keri J
    Clin Cosmet Investig Dermatol; 2022; 15():1357-1366. PubMed ID: 35874458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of hormonal agents in the treatment of acne.
    Hassoun LA; Chahal DS; Sivamani RK; Larsen LN
    Semin Cutan Med Surg; 2016 Jun; 35(2):68-73. PubMed ID: 27416311
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clascoterone as a novel treatment for androgenetic alopecia.
    Sun HY; Sebaratnam DF
    Clin Exp Dermatol; 2020 Oct; 45(7):913-914. PubMed ID: 32421862
    [No Abstract]   [Full Text] [Related]  

  • 26. Topical Antiandrogen Therapies for Androgenetic Alopecia and Acne Vulgaris.
    Marks DH; Prasad S; De Souza B; Burns LJ; Senna MM
    Am J Clin Dermatol; 2020 Apr; 21(2):245-254. PubMed ID: 31832993
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential Role for Topical Antiandrogens in the Management of Acne Among Patients Receiving Masculinizing Hormone Therapy.
    Marks DH; Mansh MD
    JAMA Dermatol; 2020 Dec; 156(12):1380-1381. PubMed ID: 33146681
    [No Abstract]   [Full Text] [Related]  

  • 28. Potential Role for Topical Antiandrogens in the Management of Acne Among Patients Receiving Masculinizing Hormone Therapy-Reply.
    Thiboutot D; Cartwright M; Mazzetti A
    JAMA Dermatol; 2020 Dec; 156(12):1381. PubMed ID: 33146696
    [No Abstract]   [Full Text] [Related]  

  • 29. Hormonal therapies in acne.
    Shaw JC
    Expert Opin Pharmacother; 2002 Jul; 3(7):865-74. PubMed ID: 12083987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Phase 1 Study to Investigate the Effects of Cortexolone 17α-Propionate, Also Known as Clascoterone, on the QT Interval Using the Meal Effect to Demonstrate ECG Assay Sensitivity.
    Täubel J; Mazzetti A; Ferber G; Burch W; Fernandes S; Patel A; Spencer CS; Freier A; Graff C; Kanters JK; Camm J
    Clin Pharmacol Drug Dev; 2021 Jun; 10(6):572-581. PubMed ID: 33942574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acne: effect of hormones on pathogenesis and management.
    Shaw JC
    Am J Clin Dermatol; 2002; 3(8):571-8. PubMed ID: 12358558
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of tazarotene cream 0.1% after a single dose and after repeat topical applications at clinical or exaggerated application rates in patients with acne vulgaris or photodamaged skin.
    Yu Z; Sefton J; Lew-Kaya D; Walker P; Yu D; Tang-Liu DD
    Clin Pharmacokinet; 2003; 42(10):921-9. PubMed ID: 12885265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sex hormones and acne: State of the art.
    Hu T; Wei Z; Ju Q; Chen W
    J Dtsch Dermatol Ges; 2021 Apr; 19(4):509-515. PubMed ID: 33576151
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of tazarotene 0.1 % cream in the treatment of facial acne vulgaris: pooled results from two multicenter, double-blind, randomized, vehicle-controlled, parallel-group trials.
    Shalita AR; Berson DS; Thiboutot DM; Leyden JJ; Parizadeh D; Sefton J; Walker PS; Gibson JR;
    Clin Ther; 2004 Nov; 26(11):1865-73. PubMed ID: 15639698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Acne vulgaris: endocrine aspects].
    Dekkers OM; Thio BH; Romijn JA; Smit JW
    Ned Tijdschr Geneeskd; 2006 Jun; 150(23):1281-5. PubMed ID: 16821451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drugs for acne.
    Med Lett Drugs Ther; 2020 Nov; 62(1612):188-191. PubMed ID: 33443492
    [No Abstract]   [Full Text] [Related]  

  • 37. Randomised controlled multiple treatment comparison to provide a cost-effectiveness rationale for the selection of antimicrobial therapy in acne.
    Ozolins M; Eady EA; Avery A; Cunliffe WJ; O'Neill C; Simpson NB; Williams HC
    Health Technol Assess; 2005 Jan; 9(1):iii-212. PubMed ID: 15588555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topical taurine bromamine, a new candidate in the treatment of moderate inflammatory acne vulgaris: a pilot study.
    Marcinkiewicz J; Wojas-Pelc A; Walczewska M; Lipko-Godlewska S; Jachowicz R; Maciejewska A; Białecka A; Kasprowicz A
    Eur J Dermatol; 2008; 18(4):433-9. PubMed ID: 18573718
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topical therapy for acne vulgaris. How do you choose the best drug for each patient?
    Johnson BA; Nunley JR
    Postgrad Med; 2000 Mar; 107(3):69-70, 73-6, 79-80. PubMed ID: 10728136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of oral isotretinoin treatment on skin androgen receptor levels in male acneic patients.
    Boudou P; Soliman H; Chivot M; Villette JM; Vexiau P; Belanger A; Fiet J
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1158-61. PubMed ID: 7714084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.